APOLLOHOSP Apollo Hospitals Enterprise Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals
Sector: Healthcare · Nifty 50 Weight: 0.36%₹ 8,498.00
+0.06%
Smart Money Verdict synthesis of derivatives, deals, and promoter files
Derivatives signal Long Buildup
Derivative traders are adding fresh longs (OI up +1.6%) on price strength (+0.2%).
Analysis what the data is telling us about APOLLOHOSP
In the last completed session, Apollo Hospitals Enterprise Ltd. closed +0.21% with futures open interest moving +1.6%. That combination — price rising while OI builds — is classified as a Long Buildup, meaning derivative traders are adding fresh bullish positions into strength rather than merely covering existing shorts. The option PCR of 0.90 is balanced — no clear directional preference from option writers. Max-pain strike at ₹8,400 sits 1.2% below the current price, a mild magnet near expiry.
There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Apollo Hospitals Enterprise Ltd. over the last 30 sessions.
Putting it together, the smart-money picture for Apollo Hospitals Enterprise Ltd. points to a supportive setup at the next open.
F&O Positioning EOD derivatives setup
Buildup Class
Long Buildup
bias: bullish
Futures OI
2,288,625
+36750 (+1.6%)
Option PCR (OI)
0.90
neutral option setup
Max Pain Strike
₹ 8,400
writer loss minimized strike
Quote Details key metrics & weights
Previous Close
₹ 8,493.00
yesterday's EOD close
Index Contribution
+0.000 pp
contribution to Nifty
Traded Volume
272,116
live shares traded today
Upcoming Earnings
—
no report scheduled
Technical Snapshot from 400 sessions of price history
RSI (14)
67.2
neutral momentum
52-Week High
₹ 8,624.00
-1.5% from high
52-Week Low
₹ 6,696.50
+26.9% above low
200-DMA
₹ 7,584.69
+12.0% · above trend
50-DMA
₹ 7,941.14
+7.0% from 50-DMA
1-Year Return
+22.6%
1M +4.7%
Key Fundamentals headline ratios · Healthcare
P/E (TTM)
62.9
price / earnings
P/B
12.9
price / book
ROE
21.5%
return on equity
Market Cap
₹ 122,188 Cr
total market value
Dividend Yield
0.24%
trailing yield
EPS (TTM)
₹ 135.12
earnings per share
Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.
Institutional Deals last 30 sessions (bulk & block)
No institutional bulk or block deals recorded for this stock in the last 30 sessions.
Insider & Promoter Filings last 60 days
No insider disclosures filed for this stock in the last 60 days.
Option Chain Ladder nearest expiry 2026-06-30 · spot 8,498 · EOD 2026-06-12
Option writers expect range between
8,300 and
9,100
—
+7.1% upside,
-2.3% downside.
upside-skewed
| Call OI (writers) | Strike | Put OI (writers) |
|---|---|---|
|
IV 22%
Δ 0.80
θ -4.5
ν 5
|
8200 |
IV 20%
Δ -0.18
θ -2.5
ν 5
|
|
IV 22%
Δ 0.76
θ -4.7
ν 6
|
8250 |
IV 19%
Δ -0.21
θ -2.7
ν 5
|
|
IV 22%
Δ 0.72
θ -5.0
ν 6
|
8300 S |
IV 19%
Δ -0.25
θ -2.8
ν 6
|
|
IV 22%
Δ 0.68
θ -5.3
ν 7
|
8350 |
IV 18%
Δ -0.29
θ -3.0
ν 6
|
|
IV 21%
Δ 0.64
θ -5.1
ν 7
|
8400 MP |
IV 18%
Δ -0.35
θ -3.1
ν 7
|
|
IV 20%
Δ 0.59
θ -5.2
ν 7
|
8450 |
IV 18%
Δ -0.40
θ -3.1
ν 7
|
|
IV 20%
Δ 0.53
θ -5.1
ν 7
|
8500 |
IV 18%
Δ -0.46
θ -3.0
ν 7
|
|
IV 20%
Δ 0.48
θ -5.0
ν 7
|
8550 |
IV 18%
Δ -0.52
θ -2.9
ν 7
|
|
IV 20%
Δ 0.43
θ -4.8
ν 7
|
8600 |
IV 17%
Δ -0.59
θ -2.6
ν 7
|
|
IV 20%
Δ 0.37
θ -4.6
ν 7
|
8650 |
IV 16%
Δ -0.66
θ -2.2
ν 7
|
|
IV 19%
Δ 0.32
θ -4.2
ν 7
|
8700 |
IV 17%
Δ -0.70
θ -2.1
ν 6
|
|
IV 20%
Δ 0.28
θ -3.9
ν 6
|
8750 |
IV 116%
Δ -0.49
θ -23.9
ν 7
|
|
IV 19%
Δ 0.23
θ -3.5
ν 6
|
8800 |
IV 15%
Δ -0.83
θ -0.7
ν 5
|
Chain Interpretation
Spot Underlying
8,498.00
Key Resistance (R)
9,100
Key Support (S)
8,300
Max Pain Strike (MP)
8,400
Concentrations of Option open interest show strong barrier levels. Option writers defend these levels, especially heading into monthly derivatives expiry.
Strategy Builder multi-leg payoff for APOLLOHOSP options · 2026-06-30 expiry
Legs
Side
Type
Strike
Qty
Premium
Net premium—
Max profit—
Max loss—
Breakevens—
Position Delta—
Position Theta/day—
Position Vega/1% IV—
Payoff at expiry
Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others
Personalised gummies firm Rem3dy Health raises funds for global push
Hijos de Rivera invests in gummies firm Rem3dy Health
From diapers to drugs: How India's global corporate hubs are putting AI to work
Apollo Hospitals Enterprise Ltd (BOM:508869) Q4 2026 Earnings Call Highlights: Record Revenue ...
India's Apollo Hospitals posts higher quarterly profit, divests fertility business
Apollo Hospitals Enterprise Ltd (BOM:508869) Q3 2026 Earnings Call Highlights: Strong Revenue ...
Indian shares pause after three-day rally
Indian hospital chain Apollo expects mid-high teens revenue growth
Apollo Hospitals Enterprise Ltd (BOM:508869) Q2 2026 Earnings Call Highlights: Strong Revenue ...
India's Apollo Hospitals misses Q2 profit view, to focus on specialty care for growth